These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

717 related articles for article (PubMed ID: 33708343)

  • 21. Expediting Molecular Translational Approach of Mesenchymal Stem Cells in COVID-19 Treatment.
    Balaji Easwaran V; Satarker S; V Gujaran T; John J; Veedu AP; George KT; Purayil DK; Beegum F; Mathew A; Vibhavari R; Chaudhari SS; Pai KSR
    Curr Stem Cell Res Ther; 2023; 18(5):653-675. PubMed ID: 36424799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Menstrual Blood-Derived Mesenchymal Stem Cell Therapy for Severe COVID-19 Patients.
    Heidari F; Heidari R; Sabet MN; Hamidieh AA; Saltanatpour Z
    Curr Stem Cell Res Ther; 2024; 19(5):644-652. PubMed ID: 37073149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm.
    Rabaan AA; Al-Ahmed SH; Muhammad J; Khan A; Sule AA; Tirupathi R; Mutair AA; Alhumaid S; Al-Omari A; Dhawan M; Tiwari R; Sharun K; Mohapatra RK; Mitra S; Bilal M; Alyami SA; Emran TB; Moni MA; Dhama K
    Vaccines (Basel); 2021 Apr; 9(5):. PubMed ID: 33946736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesenchymal Stem Cells Therapy for COVID-19: From Basic Research to Clinical Trial.
    Tao YC; Chen EQ
    Curr Stem Cell Res Ther; 2024; 19(1):55-62. PubMed ID: 36654468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics.
    Qin H; Zhao A
    Protein Cell; 2020 Oct; 11(10):707-722. PubMed ID: 32519302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can mesenchymal stem cells be used to treat COVID-19-induced pneumonia? (Review).
    Çetin İ; Topçul M
    Biomed Rep; 2020 Dec; 13(6):62. PubMed ID: 33194191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can mesenchymal stem cell therapy be the interim management of COVID-19?
    Bamba C; Singh SP; Choudhury S
    Drug Discov Ther; 2020 Jul; 14(3):139-142. PubMed ID: 32554953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesenchymal stem/stromal cell-based therapies for severe viral pneumonia: therapeutic potential and challenges.
    Masterson CH; Ceccato A; Artigas A; Dos Santos C; Rocco PR; Rolandsson Enes S; Weiss DJ; McAuley D; Matthay MA; English K; Curley GF; Laffey JG
    Intensive Care Med Exp; 2021 Dec; 9(1):61. PubMed ID: 34970706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action.
    Sadeghi S; Soudi S; Shafiee A; Hashemi SM
    Life Sci; 2020 Dec; 262():118493. PubMed ID: 32979360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Facing the Challenges in the COVID-19 Pandemic Era: From Standard Treatments to the Umbilical Cord-Derived Mesenchymal Stromal Cells as a New Therapeutic Strategy.
    Russo E; Corrao S; Di Gaudio F; Alberti G; Caprnda M; Kubatka P; Kruzliak P; Miceli V; Conaldi PG; Borlongan CV; La Rocca G
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm.
    Kavianpour M; Saleh M; Verdi J
    Stem Cell Res Ther; 2020 Sep; 11(1):404. PubMed ID: 32948252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
    Quirch M; Lee J; Rehman S
    J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obesity and COVID-19: Molecular Mechanisms Linking Both Pandemics.
    Ritter A; Kreis NN; Louwen F; Yuan J
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32806722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment.
    Jayaramayya K; Mahalaxmi I; Subramaniam MD; Raj N; Dayem AA; Lim KM; Kim SJ; An JY; Lee Y; Choi Y; Raj A; Cho SG; Vellingiri B
    BMB Rep; 2020 Aug; 53(8):400-412. PubMed ID: 32731913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical progress: Stem cells as a new therapeutic strategy for COVID-19.
    Musial C; Gorska-Ponikowska M
    Stem Cell Res; 2021 Apr; 52():102239. PubMed ID: 33601098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges for Mesenchymal Stem Cell-Based Therapy for COVID-19.
    Li C; Zhao H; Wang B
    Drug Des Devel Ther; 2020; 14():3995-4001. PubMed ID: 33061304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do inflammaging and coagul-aging play a role as conditions contributing to the co-occurrence of the severe hyper-inflammatory state and deadly coagulopathy during COVID-19 in older people?
    Exp Gerontol; ; . PubMed ID: 34048906
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.